Combining personalized neoantigen vaccination with chemotherapy and anti-PD-1 to treat NSCLC by Leung, CSK, Van den Eynde, BJ

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression by Ramirez-Valdez, RA, Baharom, F, Khalilnezhad, A, Fussell, SC, Hermans, DJ, Schrager, AM, Tobin, KKS, Lynn, GM, Khalilnezhad, S, Ginhoux, F, Van den Eynde, BJ, Leung, CSK, Ishizuka, AS, Seder, RA

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy by McAuliffe, J, Chan, HF, Noblecourt, L, Ramirez-Valdez, RA, Pereira-Almeida, V, Zhou, Y, Pollock, E, Cappuccini, F, Redchenko, I, Hill, AV, Leung, CSK, Van den Eynde, BJ